SCHEMBL4355546

SCHEMBL4355546

O=C1N=C(NCc2ccc3c(c2)OCO3)S/C1=C\c1ccc(C(F)(F)F)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.43
FAAH O00519 1/20 0.41
PIM1 P11309 1/20 0.40
PIM2 Q9P1W9 1/20 0.40
SCN9A Q15858 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PIK3CG P48736 2/20 0.39
ALDH1A1 P00352 2/20 0.39
PTPN1 P18031 1/20 0.39
FLT1 P17948 2/20 0.38
KDR P35968 2/20 0.38
TRPV1 Q8NER1 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
USP1 O94782 1/20 0.37
WDR48 Q8TAF3 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4355549 1.00 HPGD (0.43) HPGDFAAHPIM1PIM2SCN9A
SCHEMBL4350119 0.88 HPGD (0.48) HPGDPIM1PIM2HSD17B10ALDH1A1
SCHEMBL4350122 0.88 HPGD (0.48) HPGDPIM1PIM2HSD17B10ALDH1A1
SCHEMBL4351555 0.80 MAPK1 (0.43) HSD17B10ALDH1A1TRPV1L3MBTL1HDAC3
SCHEMBL4873444 0.79 CLK4 (0.45) HPGDPIM1PIK3CGALDH1A1FLT1
SCHEMBL4354245 0.77 PTPN1 (0.45) PIM1PIM2PTPN1
SCHEMBL4354241 0.77 PTPN1 (0.45) PIM1PIM2PTPN1
SCHEMBL4363199 0.77 ALOX5 (0.44) PIM1PIM2
SCHEMBL4355386 0.77 KDM4E (0.47) HPGDALDH1A1FLT1KDRL3MBTL1
SCHEMBL4355388 0.77 KDM4E (0.47) HPGDALDH1A1FLT1KDRL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 HPGD 770/4885FAAH 4512/4885PIM1 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.